Hyperviscosity Syndrome in Cryoglobulinemia: Clinical Aspects and Therapeutic Considerations

Seminars in Thrombosis and Hemostasis

Volumn 29, Issue 5, 2003, Pages 473-477

  Della Rossa, Alessandra ^a   Tavoni, Antonio ^a   Bombardieri, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Cryoglobulinemia; Hemorheology; Hyperviscosity syndrome; Management; Mixed; Monoclonal; Plasma exchange

Indexed keywords

ALPHA INTERFERON; CYTOTOXIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; RIBAVIRIN; STEROID;

BLOOD RHEOLOGY; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; CRYOGLOBULINEMIA; DIET THERAPY; DISEASE COURSE; DISEASE SEVERITY; HEMODYNAMIC MONITORING; HUMAN; HYPERVISCOSITY SYNDROME; INCIDENCE; LYMPHOPROLIFERATIVE DISEASE; NONHODGKIN LYMPHOMA; PLASMAPHERESIS; PRECIPITATION; PRIORITY JOURNAL; REVIEW; TEMPERATURE SENSITIVITY; TREATMENT INDICATION; VASCULITIS;

BLOOD VISCOSITY; CRYOGLOBULINEMIA; DISEASE MANAGEMENT; HEMATOLOGIC DISEASES; HUMANS; SYNDROME;

EID: 0242266979     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-44555     Document Type: Review

References (24)

1. Brouet JC, Clauvel JP, Danon F, Klein M, Seligman M. Biologic report and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974;57:775-788
2. Della Rossa A, Ferri C, Bombardieri S. From essential mixed cryoglobulinemia to virus induced autoimmnunity: ten years of research in mixed cryoglobulinemia. In: Shoenfeld Y, ed. The Decade of Autoimmunity. Amsterdam: Elsevier Sciences; 1999:235-243
3. Winfield JB. Cryoglobulinemia. Hum Pathol 1983;14:350-354
4. Buxbaun J. Hyperviscosity syndrome in dysproteinemias. Am J Med Sci 1972;264:123-126
5. Siami GA, Siami F. Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenström's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis. Ther Apher 1999;3:8-19
6. Gorevich PD, Kassab HJ, Levo Y, et al. Mixed cryoglobulinemia: clinical aspects and long term follow up of 40 patients. Am J Med 1980;69:287-308
7. Ferri C, La Civita L, Longombardo G, Zignego AL, Pasero G. Mixed cryoglobulinemia: a cross road between autoimmune and lymphoproliferative disorders. Lupus 1998;7:275-279
8. Ferri C, Mannini L, Bartoli V. Blood viscosity and filtration abnormalities in MC patients. Clin Exp Rheumatol 1990;8: 271-281
9. Carter PW, Cohen HJ, Crawford J. Hyperviscosity syndrome in association with kappa light myeloma. Am J Med 1989; 86:591
10. Kosmo MA, Gale RP. Plasma cell leukemia with IgA paraproteinemia and hyperviscosity. Am J Hematol 1988;28:113-115
11. Avnstorp C, Nielsen H, Drachman O, Hippe E. Plasmapheresis in hyperviscosity synmdrome. Acta Med Scand 1985;217:133-137
12. Jasin HE, LoSpalluto J, Ziff M. Rheumatoid hyperviscosity syndrome. Am J Med 1970;49:484-493
13. Abruzzo JL, Heimer R, Giuliano V, Martinez J. The hyperviscosity syndrome, polysynovitis, polymyositis and unusual 13s serum IgG component. Am J Med 1970;49:258-264
14. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia. A clinical and laboratory study. Cryoglobulins with rheumatoid factor activity. Am J Med 1966;40: 837-856
15. Stone MG. Studies on monoclonal antibodies. I. The specificity and binding properties of a Waldenström macroglobulinemia with anti Ig-G activity. J Lab Clin Med 1973;81: 393-409
16. Galli M, Monti G, Invernizzi F, et al. Hepatitis B virus-related markers in secondary and essential mixed cryoglobulinemias: a multicentre study of 596 cases. Ann Ital Med Int 1992;7:209-214
17. Ferri C, Greco F, Longombardo G, et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991;34:1606-1610
18. Ferri C, Greco F, Longombardo G, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991;9:621-624
19. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-1495
20. Tavoni A, Mosca M, Ferri C, et al. Guidelines for the management of essential mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13(suppl 13):S191-S195
21. Lunel F, Cacoub P. Treatment of autoimmune and extrahepatic manifestations of HCV infection. Ann Med Interne (Paris) 2000;151:58-64
22. Beck JR, Quinn BM, Meier FA, Rawnsley HM. Hyperviscosity syndrome in paraproteinemia. Managed by plasma exchange, monitored by serum tests. Transfusion 1982;22:51-53
23. Bombardieri S, Ferri C, Migliorini P, et al. Immune complex behaviour during prolonged plasma exchange in essential mixed cryoglobulinemia and lupus erythematosus. Int J Artif Organs 1984;8:7-10
24. Bombardieri S, Caponi L, Pilo A, et al. Changes in the putative antigen/antibody ratio of circulating immune complexes in mixed cryoglobulinemia and systemic lupus erythematosus following selective removal of macromolecules. Int J Artif Organs 1989;12(suppl 4):87-91